IL-6 receptor antagonist

This page covers all IL-6 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-6R (Interleukin-6 receptor), IL-6 receptor (IL-6R), IL-6R.

Targets

IL-6R (Interleukin-6 receptor) · IL-6 receptor (IL-6R) · IL-6R

Marketed (2)

• Ro-Actemra · Medical University of Vienna · Immunology
  Ro-Actemra (tocilizumab) is an IL-6 receptor antagonist that blocks interleukin-6 signaling to reduce inflammatory responses.
• Placebo to tocilizumab · Hoffmann-La Roche · Immunology
  Tocilizumab is a monoclonal antibody that blocks the interleukin-6 (IL-6) receptor, inhibiting the pro-inflammatory IL-6 signaling pathway.

Phase 3 pipeline (9)

• Actemra(EU-licensed) · Bio-Thera Solutions · Immunology
  Actemra (tocilizumab) is an IL-6 receptor antagonist that blocks interleukin-6 signaling to reduce inflammatory responses.
• Placebo to GSK3196165/ Sarilumab · GlaxoSmithKline · Immunology
  Sarilumab is a monoclonal antibody that blocks the interleukin-6 receptor (IL-6R), reducing inflammatory signaling in immune-mediated diseases.
• placebo to tocilizumab SC · Hoffmann-La Roche · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.
• placebo to tocilizumab IV · Hoffmann-La Roche · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.
• tocilizumab SC · Hoffmann-La Roche · Immunology
  Tocilizumab SC is an interleukin-6 receptor antagonist that blocks the action of interleukin-6, a cytokine involved in inflammation.
• Tociliziumab group · Biogipuzkoa Health Research Institute · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response.
• Tocilizumab treatment · Centre Hospitalier Universitaire Dijon · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.
• Tocilizumab Prefilled Syringe [Actemra] · Medical University of Vienna · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.
• Tocilizumab Injection · Abderrahmane Mami Hospital · Immunology
  Tocilizumab Injection is an interleukin-6 receptor antagonist that blocks the action of interleukin-6, a cytokine involved in inflammation.

Phase 2 pipeline (1)

• AMG 714 · Amgen · Immunology
  AMG 714 is an interleukin-6 (IL-6) receptor antagonist that blocks IL-6 signaling to reduce inflammation.